ArticleFrontiers in immunology2025

Neoadjuvant outperforms adjuvant regimens in resectable advanced Chinese melanoma patients: lymph node preservation as a key immunological advantage.

Shuguang Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.